Shoutout to @GEHealthCare for their generous giving to #StepUpForFAER & supporting the establishment of a new #FAERgrant for clinical investigators! Giving like theirs helps make FAER’s work possible, & we’re honored to have them as a supporter! 😊 https://t.co/xbL8eK878u #ANES24
A new issue is out today! In the cover study, a single, local administration of vocacapsaicin during surgery reduced pain and opioid consumption for at least 96 hours after surgery compared to control. Read the article: https://t.co/KGRTEd1vg2
An exciting new role has been posted: Medical Director, Diagnostic Cardiology. This is an incredible opportunity to join GE HealthCare and work closely with our preeminent Diagnostic Cardiology team.
#gehealthcare#cardiology#futureofhealthcare https://t.co/sU7fOvkCjb
I am excited to share the news that GE Healthcare is now an industry supporter of the American Society of Anesthesiologists! We are looking forward to partnering with ASA to advance the field of anesthesiology. #ANES22. https://t.co/yUdnkhz0CQ
Influential article by Hubert Joly in HBR on corporate purpose https://t.co/W6MNZmNUvF which references a great TED Talk from Simon Sinek on leadership https://t.co/RxrkgxnWMt. Both serve as great references for leaders. #leadership#Inspire#purpose
Great overview on the specialty of anesthesia embracing academic rigor, developing standards of practice, and leveraging technology to improve patient outcomes. @ASALifeline@APSForg#patientsafety
Special article from Dr. Mark Warner and Dr. Mary Warner reviews the nascent anesthesia patient safety movement which generated highly successful and innovative patient safety initiatives. https://t.co/Z3FjZHPaqt
Comparative kinetics of humoral and cellular immune responses elicited by COVID-19 vaccines in @NEJM. See CDC data summarized in Axios for follow on review. @axios
B-cell and T-cell responses were measured to assess the stability of vaccine-induced immunity. BNT162b2 and mRNA-1273 responses peaked early, declining over 8 months. The response to Ad26.CoV2.S reached a lower peak. #Covid19vaccine#IDTwitter https://t.co/DNKGTCyH7H
Young children are at risk for severe #COVID19. COVID-NET data for the week ending Sept. 25 show that rates of COVID-19-associated hospitalizations in children ages 5–11 years are the highest they've been. Get vaccinated to help slow the spread. More: https://t.co/qpYN3dSJL8
Happy #EtherDay to anesthesia professionals around the world! On this day in 1846, dentist William T.G. Morton successfully demonstrated the use of ether to prevent surgical pain. Today is also known as #WorldAnaesthesiaDay.
#anesthesia#anesthesiology#WAD2021
Analysis found no significant associations between vaccination with mRNA #COVID19 vaccines and selected serious health outcomes 1-21 days after vaccination, although confidence intervals were wide for some rate ratio estimates and additional follow up https://t.co/Ihb7jEIUtP
What does the future of corona virus vaccines look like? Clues from Chee-Wah Tan, Ph.D. et al. in @NEJM. Pan-Sarbecovirus neutralizing antibodies identified in SARS-CoV-1 survivors who have been vaccinated for SARS-CoV-2 (COVID-19). https://t.co/sSIyzSwiTj #COVID#vaccination
Anesthesia research published in @NEJM. Patients receiving spinal vs GA for hip fracture compared. Similar outcomes - including postop delirium. Results add to understanding implications of anesthetic choice in this scenario. @APSForg#ANES21#patientsafety
In this trial, spinal anesthesia was compared with general for hip-fracture surgery in adults 50 or older. Spinal anesthesia was not superior with respect to a composite of death or an inability to walk. #ANES21 https://t.co/4EoygYFSTL
As a patient, you can take steps to reduce your risk of #sepsis. Follow these simple tips to protect yourself and your family: https://t.co/rSkIkgkT4b. #SAM2021
The data that millions of parents have been waiting for is close to review by the FDA and global regulatory authorities. Fingers crossed for prompt EUA in the US and internationally. #Vaccines#Pediatrics#schoolreopening#COVID19Vaccines#COVID19
Today with @BioNTech_Group, we are proud to announce positive topline results from the pivotal trial of our #COVID19 vaccine in children 5-11 years of age. https://t.co/a1mSEgxNHQ